No Data
No Data
Andon Health (002432.SZ): Cumulatively repurchased 5.96% of shares.
Andon Health (002432.SZ) announced that as of July 31, 2024, the company has repurchased a total of 29,226,340 shares of the company through a stock buyback special securities account using centralized bidding trading method, accounting for 5.96% of the total share capital of the company. The highest fill price was 41.277 yuan/share, the lowest fill price was 39.42 yuan/share, and the total payment amount was RMB 1,179,517,884.38 (excluding transaction fees). This buyback complies with relevant laws and regulations, and is in line with the company's established buyback plan.
Andon Health (002432.SZ): iHealth's triple test kits for novel coronavirus, influenza A virus and influenza B virus have been sold through online and offline channels.
On July 24th, Glon Hui reported that Andon Health (002432.SZ) stated on the investor interaction platform that the company’s iHealth novel coronavirus, influenza A virus and influenza B virus triple detection test kit has been sold through both online and offline channels. The online sales channels include the subsidiary's official website in the USA, Amazon platform, etc., mainly for TOC sale, and the offline channels include TOB and TOC sale. The product has a short time on the market, and its sales situation cannot be predicted. Please pay attention to the company's periodic reports for the specific sales revenue information. The company will closely monitor market demand and further develop the product.
Andon Health (002432.SZ): The prototype of continuous glucose monitoring system (CGMS) has been completed and is currently undergoing pre-clinical trials.
On July 24th, Gelunhui reported that Andon Health (002432.SZ) stated on its investor interaction platform that the prototype of the company's continuous glucose monitoring system (CGMS) has been completed and is currently undergoing pre-clinical trials. This project is a core business related to the company's global strategy, and the company will focus its energy and resources on accelerating the progress of this project. CGMS can provide continuous data on changes in blood glucose levels, which is important for revealing hidden high and low blood sugar events. In addition, through the analysis of blood sugar profiles, CGMS can help users understand the impact of lifestyle habits (such as diet, exercise, etc.) on blood sugar levels, and ...
Andon Health (SZSE:002432) Is Looking To Continue Growing Its Returns On Capital
Andon Health (002432.SZ): As of the end of May 2024, the number of company shareholders is approximately 0.0924 million households.
Andon Health (002432.SZ) stated on the investor interaction platform on July 12th that as of the end of May 2024, the company had approximately 0.0924 million shareholders.
Andon Health (002432.SZ): Cumulative Buyback of 5.96% of Shares.
Andon Health (002432.SZ) announced that as of June 30, 2024, the company has repurchased a total of 29,226,340 shares of the company through a share buyback dedicated securities account in the centralized bidding transaction, accounting for 5.96% of the total share capital of the company, with a highest fill price of 41.277 yuan/share and a lowest fill price of 39.42 yuan/share, and the total amount paid was RMB 1,179,517,884.38 (excluding transaction costs). This buyback is in accordance with relevant laws and regulations and the company's established buyback plan.
No Data